Publications 2021

Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegard KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Gotz A, Holm K, Aukrust P, Akra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Troseid M, Broch K (2021)
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
EBioMedicine, 70, 103511
DOI 10.1016/j.ebiom.2021.103511

Nordeng J, Schandiz H, Solheim S, Akra S, Hoffman P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2021)
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
Mediat. Inflamm., 2021, 5525917
DOI 10.1155/2021/5525917

Zaidi H, Byrkjeland R, Njerve IU, Akra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2021)
Adiponectin in relation to exercise and physical performance in patients with type 2 diabetes and coronary artery disease
Adipocyte, 10 (1), 612-620
DOI 10.1080/21623945.2021.1996699

Publications 2020

Akra S, Aksnes TA, Laa AF, Eggesbo HB, Pstad TBO, Jerve IUN, Seljeflot I (2020)
Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men
Sci Rep, 10 (1), 14055
DOI 10.1038/s41598-020-71109-4

Publications 2019

Dhillon AK, Kummen M, Troseid M, Akra S, Liaskou E, Moum B, Vesterhus M, Karlsen TH, Seljeflot I, Hov JR (2019)
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
Liver Int., 39 (2), 371-381
DOI 10.1111/liv.13979

Zaidi H, Byrkjeland R, Njerve IU, Akra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial
Diabetes Vasc. Dis. Res., 16 (4), 360-368
DOI 10.1177/1479164119836922

Zaidi H, Byrkjeland R, Njerve IU, Akra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial
Diabetol. Metab. Syndr., 11 (1), 109
DOI 10.1186/s13098-019-0508-9

Publications 2018

Akra S, Aksnes TA, Flaa A, Eggesbo HB, Opstad TB, Njerve IU, Seljeflot I (2018)
Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men
Diabetes Vasc. Dis. Res., 15 (5), 458-464
DOI 10.1177/1479164118785307

Publications 2017

Njerve IU, Akra S, Weiss TW, Solheim S, Ovstebo R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
Mediat. Inflamm., 2017, 5380638
DOI 10.1155/2017/5380638

Publications 2016

Njerve IU, Byrkjeland R, Arnesen H, Akra S, Solheim S, Seljeflot I (2016)
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
Diabetes Metab. Syndr. Obes., 9, 55-62
DOI 10.2147/DMSO.S96299

Publications 2012

Opstad TB, Pettersen AAR, Weiss TW, Akra S, Ovstebo R, Arnesen H, Seljeflot I (2012)
Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease
Clin. Chim. Acta, 413 (1-2), 113-120
DOI 10.1016/j.cca.2011.09.004